A Phase 4 interventional study of Ropivacaine 0.2% for PENG Block and Ropivacaine 0.2% for LFCB in Hip Disease, Hip Dysplasia and Hip Arthropathy, sponsored by Poznan University of Medical Sciences. Recruiting at 1 site in Poland. Open to participants aged 2 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Poznan University of Medical Sciences · Phase 4, Interventional, and Treatment
This randomized controlled trial (RCT) compares the analgesic effectiveness of two regional anesthesia techniques-Pericapsular Nerve Group (PENG) block combined with Lateral Femoral Cutaneous Nerve Block (LFCB) versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB)-in pediatric patients undergoing hip surgery.
Orthopedic hip procedures in pediatric patients, including osteotomies, arthroscopic interventions, and reconstructive surgeries, often result in significant postoperative pain. Effective analgesia is critical for reducing surgical stress, accelerating rehabilitation, and minimizing opioid use and associated side effects. Regional anesthesia techniques have gained attention for their opioid-sparing effects and enhanced recovery profiles.
This randomized controlled trial aims to compare the analgesic effectiveness of two regional anesthetic approaches:
- The pericapsular nerve group (PENG) block is combined with the lateral fetal cutaneous nerve block (LFCB), targeting hip joint innervation directly and providing comprehensive sensory coverage.
Lumbar and sacral erector spinae plane blocks (L-ESPB and S-ESPB) employ fascial plane techniques to deliver analgesia by diffusing local anesthetic around nerves innervating the hip region.
This trial aims to establish the optimal regional anesthesia technique and determine the clinical benefits of using dexamethasone and dexmedetomidine as adjuvants. The results will guide clinicians toward evidence-based analgesic protocols in pediatric orthopedic hip surgery, potentially reducing opioid-related complications and improving patient recovery outcomes.
107 studies on the registry are indexed under Hip Dislocation; 36 are open to participants now.
This study's planned enrollment of 60 is below the median of 86 across 64 interventional studies indexed under Hip Dislocation.
Browse Hip Dislocation studies →Poznan University of Medical Sciences is the lead sponsor of 151 studies on the registry; 41 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
U-S guided PENG block - 0.4ml/kg 0.2% ropivacaine \+ U-S guided LFCB - 0.1ml/kg 0.2% ropivacaine
Drug: Ropivacaine 0.2% for PENG Block · Drug: Ropivacaine 0.2% for LFCB
U-S guided L-ESPB - 0.25ml/kg 0.2% ropivacaine \+ U-S guided S-ESPB - 0.25ml/kg 0.2% ropivacaine
Drug: Ropivacaine 0.2% for L-ESPB · Drug: Ropivacaine 0.2% for S-ESPB
U-S guided PENG (0.4 mL/kg) with 0.2% ropivacaine
LFCB (0.1 mL/kg) with 0.2% ropivacaine
Lumbar ESPB (0.25ml/kg) with 0.2% ropivacaine
Sacral ESPB (0.25ml/kg) with 0.2% ropivacaine
Total Opioid Consumption
Total opiate consumption after surgery
Time frame: 48 hours after surgery
Time to first rescue opioid analgesia
Time after surgery when the patient needs opiate for the first time
Time frame: 48 hours after surgery
Numerical Rating Scale [range 0:10]
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 4 hours after surgery
Numerical Rating Scale [range 0:10]
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 8 hours after surgery
Numerical Rating Scale [range 0:10]
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 12 hours after surgery
Numerical Rating Scale [range 0:10]
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 24 hours after surgery
Numerical Rating Scale [range 0:10]
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 48 hours after surgery
NLR
neutrophile to lymphocyte ratio
Time frame: 12 hours after surgery
NLR
neutrophile to lymphocyte ratio
Time frame: 24 hours after surgery
NLR
neutrophile to lymphocyte ratio
Time frame: 48 hours after surgery
PLR
platelet to lymphocyte ratio
Time frame: 12 hours after surgery
PLR
platelet to lymphocyte ratio
Time frame: 24 hours after surgery
PLR
platelet to lymphocyte ratio
Time frame: 48 hours after surgery
Plan to share: Yes
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ropivacaine
Poznan University of Medical Sciences →